Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck-Reference-Cited by-同舟云学术

Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck

Published:2002-07-11 Issue:2 Volume:95 Page:322-330
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Shin Dong M.,Glisson Bonnie S.,Khuri Fadlo R.,Lippman Scott M.,Ginsberg Lawrence,Diaz Edward,Papadimitrakopoulou Vassiliki,Feng Lei,Francisco Marites,Garden Adam,Kies Merrill S.,Myers Jeffrey,Clayman Gary,Hong Waun Ki

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Head and Neck Cancer

2. Tumors of the nasal cavity and paranasal sinuses, nasopharynx, oral cavity, and oropharynx. In: Cancer principles and practice of oncology. 5th edition. Philadelphia: Lippincott-Raven, 1997: 741-801.

3. Nutritional management of the head and neck cancer patient

4. Predicting Postoperative Head and Neck Complications Using Nutritional Assessment: The Prognostic Nutritional Index

5. Head and neck cancer. In: Cancer medicine. 4th edition. Baltimore: Williams & Wilkins, 1996: 1645-1710.

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PRMT1 Inhibition Selectively Targets BNC1-Dependent Proliferation, but not Migration in Squamous Cell Carcinoma;2023-03-27

2. Induction chemotherapy in nonlaryngeal human papilloma virus-negative high-risk head and neck cancer: a real-world experience;Anti-Cancer Drugs;2020-09-10

3. Organ-preservation (chemo)radiotherapy for T4 laryngeal and hypopharyngeal cancer: is the effort worth?;European Archives of Oto-Rhino-Laryngology;2018-12-18

4. Management of advanced hypopharyngeal carcinoma: systematic review of survival following surgical and non-surgical treatments;The Journal of Laryngology & Otology;2018-05

5. An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients;South Asian Journal of Cancer;2016-04